Remel BLOOD AGAR EMB AGAR BIPLATE recalled over Listeria risk

Recall date

February 13, 2025

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Official notice title

Remel, Inc recalls remel BLOOD AGAR EMB AGAR BIPLATE, REF R02041, QTY 100, for invitro diagnostic use

Recall number

Z-1201-2025

FDA classification

Class II

Brand / firm

Remel, Inc

Sold / distributed

US Nationwide distribution.

Why it was recalled

Product may contain surface and subsurface contamination of Listeria monocytogenes which is typically visible immediately upon removal from the packaging, appearing on the blood side of the biplate.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

remel BLOOD AGAR EMB AGAR BIPLATE, REF R02041, QTY 100, for invitro diagnostic use